Daily cyclophosphamide for scleroderma: are patients with the most to gain underrepresented in this trial?
- PMID: 17984310
- DOI: 10.1164/rccm.200708-1185ED
Daily cyclophosphamide for scleroderma: are patients with the most to gain underrepresented in this trial?
Comment on
-
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.Am J Respir Crit Care Med. 2007 Nov 15;176(10):1026-34. doi: 10.1164/rccm.200702-326OC. Epub 2007 Aug 23. Am J Respir Crit Care Med. 2007. PMID: 17717203 Free PMC article. Clinical Trial.
Similar articles
-
Adverse events during the Scleroderma Lung Study.Am J Med. 2011 May;124(5):459-67. doi: 10.1016/j.amjmed.2010.12.009. Am J Med. 2011. PMID: 21531236 Clinical Trial.
-
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.Arthritis Rheum. 2006 Dec;54(12):3962-70. doi: 10.1002/art.22204. Arthritis Rheum. 2006. PMID: 17133610 Clinical Trial.
-
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.Am J Respir Crit Care Med. 2007 Nov 15;176(10):1026-34. doi: 10.1164/rccm.200702-326OC. Epub 2007 Aug 23. Am J Respir Crit Care Med. 2007. PMID: 17717203 Free PMC article. Clinical Trial.
-
[Pulmonary arterial hypertension in collagen disease: experiences of the German Network for Systemic Scleroderma].Dtsch Med Wochenschr. 2006 Dec 8;131(49 Suppl 9):S325-7. doi: 10.1055/s-2006-957203. Dtsch Med Wochenschr. 2006. PMID: 17139598 Review. German.
-
[Advances in the treatment of scleroderma].Med Clin (Barc). 1984 Jun 9;83(2):74-7. Med Clin (Barc). 1984. PMID: 6147448 Review. Spanish. No abstract available.
Cited by
-
Efficacy of cyclophosphamide for skin fibrosis in systemic sclerosis: a systematic review and single-arm meta-analysis.Eur J Clin Pharmacol. 2025 Jun;81(6):863-874. doi: 10.1007/s00228-025-03837-3. Epub 2025 Apr 8. Eur J Clin Pharmacol. 2025. PMID: 40198334
-
Update on diffuse parenchymal lung disease.Eur Respir Rev. 2010 Jun;19(116):97-108. doi: 10.1183/09059180.00002510. Eur Respir Rev. 2010. PMID: 20956177 Free PMC article. Review. No abstract available.
-
Rapidly progressive fatal interstitial lung disease in a patient with systemic sclerosis.Nat Rev Rheumatol. 2009 Apr;5(4):225-8. doi: 10.1038/nrrheum.2009.30. Nat Rev Rheumatol. 2009. PMID: 19337287
-
Management of interstitial lung disease associated with connective tissue disease.BMJ. 2016 Feb 24;352:h6819. doi: 10.1136/bmj.h6819. BMJ. 2016. PMID: 26912511 Free PMC article. Review.
-
Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis.Clin Med Insights Circ Respir Pulm Med. 2016 Jan 19;9(Suppl 1):97-110. doi: 10.4137/CCRPM.S23315. eCollection 2015. Clin Med Insights Circ Respir Pulm Med. 2016. PMID: 26819563 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical